Product Details
Visita Plus+++
Betamethasone; Clotrimazole; Neomycin sulfate0.05%; 1%; 0.35%
Cream
ROA
Topical
Applicant Name
Elbe Pharma Nigeria Limited
NRN
B4-4845
Status
Active
Composition
Visita Plus contains: Clotrimazole BP 1.0% w/w, Betamethasone Dipropionate USP Equivalent to Betamethasone 0.05 % w/w, Neomycin Sulfate USP 0.50 % w/w Equivalent to Neomycin Base 0.35 % w/w in a Cream Base Excipients: Chlorocresol, Cetomacrogol -1000, Cetostearyl Alcohol, Light Liquid Paraffin, White Soft Paraffin, Propylene Glycol, lsopropyl Myristate BP, Citric Acid Anhydrous BP, Fragrance Soft Petal AF 1023 BP, Purified Water BP
ATC Code
D07CC01
Product Category
Drugs
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 × 30 g (in LAMI Tube)
Product Description
Topical, semi-solid dosage form - cream A white soft homogeneous cream, free from gritty particles VISITA PLUS CLOTRIMAZOLE 1.0%W/W, BETAMETHAZONE DIPROPIONATE 0.05%W/W, NEOMYCIN SULPHATE 0.5%W/W VISITA PLUS (CLOTRIMAZOLE 1.0% W/W, BETAMETHAZONE DIPROPIONATE 0.05% W/W, NEOMYCIN SULPHATE 0.5% W/W) B4-4845 Drugs Imported Products 1X30G Prescription Only Medicine (POM) 16/12/2022 ELBE PHARMA NIGERIA LIMITED, 1, AFRICAN CHURCH CLOSE, OFF COKER ROAD, ILUPEJU, LAGOS STATE, NIGERIA. 8069718539 elbepharma.rgn@gmail.com S. KANT HEALTHCARE LTD, 1802-1805, GIDC, PHASE 111, VAPI 396 195, GUJARAT, INDIA, India
Manufacturer Name
S Kant Healthcare Ltd
Manufacturer Country
INDIA
Approval Date
2023-04-26
Expiry Date
2028-04-25